-
Mashup Score: 4Pharmalittle: We're reading about a Novo Nordisk deal, a Regeneron setback, and more - 2 month(s) ago
Novo Nordisk agreed to acquire Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional cardiometabolic drug candidates.
Source: www.statnews.comCategories: General Medicine News, General NewsTweet
Pharmalot.. Pharmalittle.. Good Morning: We’re reading about a Novo Nordisk deal, a Regeneron setback & more news.. https://t.co/8vaZPk6fP1 #pharma #Covid #Alzheimer #abortion #AIDS #insulin #weightloss #obesity #Wegovy #SCOTUS $NVO $LLY $BNTX $PFE $REGN $EISAIY